$531 Million is the total value of Foyston, Gordon, & Payne Inc's 62 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTX | Buy | United Technologies Corp. | $32,074,000 | +12.5% | 214,169 | +2.5% | 6.04% | +6.5% |
| AXP | Buy | American Express | $23,783,000 | +10.0% | 191,044 | +4.5% | 4.48% | +4.1% |
| CSCO | Buy | Cisco Systems Inc. | $20,682,000 | -2.4% | 431,234 | +0.5% | 3.89% | -7.6% |
| TFC | New | Truist Financial Corp | $13,387,000 | – | 237,689 | +100.0% | 2.52% | – |
| ORCL | Buy | Oracle Corp. | $13,108,000 | -3.7% | 247,419 | +0.0% | 2.47% | -8.8% |
| BAX | Buy | Baxter International Inc. | $12,084,000 | -3.6% | 144,510 | +0.8% | 2.28% | -8.8% |
| CTVA | Buy | Corteva Inc. | $9,165,000 | +141.6% | 310,050 | +128.8% | 1.73% | +128.6% |
| DD | Buy | Dupont de Nemours Inc. | $8,686,000 | +18.7% | 135,296 | +31.8% | 1.64% | +12.3% |
| CHRW | Buy | C.H. Robinson Worldwide Inc. | $8,543,000 | -6.2% | 109,244 | +1.7% | 1.61% | -11.3% |
| GNTX | Buy | Gentex Corp. | $7,627,000 | +6.9% | 263,169 | +1.6% | 1.44% | +1.2% |
| NVS | Buy | Novartis AG - ADR | $6,857,000 | +12.0% | 72,413 | +2.8% | 1.29% | +6.0% |
| BTI | Buy | British American Tobacco PLC - ADR | $4,139,000 | +17.3% | 97,486 | +2.0% | 0.78% | +11.0% |
| SONY | New | Sony Corp. - Spon ADR | $3,283,000 | – | 48,275 | +100.0% | 0.62% | – |
| EWC | New | iShares MSCI Canada ETF | $215,000 | – | 7,200 | +100.0% | 0.04% | – |
| USB | New | U.S. Bancorp. | $205,000 | – | 3,463 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp. | 42 | Q3 2023 | 10.2% |
| Johnson & Johnson | 42 | Q3 2023 | 9.3% |
| Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
| Coca Cola Co. | 42 | Q3 2023 | 1.7% |
| Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
| Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
| Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
| AbbVie Inc. | 42 | Q3 2023 | 0.5% |
| Abbott Laboratories | 42 | Q3 2023 | 0.4% |
| Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
| Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
| TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
| CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.